Levobetaxolol

DB09351ApprovedSmall molecule

Levobetaxolol is a beta-blocker used to lower the pressure in the eye to treat conditions such as glaucoma. It was marketed as a 0.5% ophthalmic solution of levobetaxolol hydrochloride under...

Chemical structure of Levobetaxolol
Mechanism
Curator reviewed · 1 reference
Primary indication
Used in the treatment of open-angle glaucoma and ocular hypertension.Curator reviewed
Formula / weight
C18H29NO3 · 307.434 g/mol (avg)
Also known as
(S)-betaxolol

Resolves to

Clinical / RWD
Structure
InChIKeyNWIUTZDMDHAVTP-KRWDZBQOSA-NSMILESCC(C)NC[C@H](O)COC1=CC=C(CCOCC2CC2)C=C1

What you can answer from here — as of September 23, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
1,084Drug interactionsStructured to mechanism, not free text
Sign in
2Clinical trialsPhase, status and sponsor resolved per trial
Sign in
9+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Levobetaxolol, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account